Andre Lagrange
Last active: 3/14/2018


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination. Grier MD, West KL, Kelm ND, Fu C, Does MD, Parker B, McBrier E, Lagrange AH, Ess KC, Carson RP (2017) PLoS One 12(11): e0188417
    › Primary publication · 29161318 (PubMed) · PMC5697806 (PubMed Central)
  2. Temporal lobe origin is common in patients who have undergone epilepsy surgery for hypermotor seizures. Arain AM, Azar NJ, Lagrange AH, McLean M, Singh P, Sonmezturk H, Konrad P, Neimat J, Abou-Khalil B (2016) Epilepsy Behav 64(Pt A): 57-61
    › Primary publication · 27732917 (PubMed)
  3. Comparison of γ-Aminobutyric Acid, Type A (GABAA), Receptor αβγ and αβδ Expression Using Flow Cytometry and Electrophysiology: EVIDENCE FOR ALTERNATIVE SUBUNIT STOICHIOMETRIES AND ARRANGEMENTS. Botzolakis EJ, Gurba KN, Lagrange AH, Feng HJ, Stanic AK, Hu N, Macdonald RL (2016) J Biol Chem 291(39): 20440-61
    › Primary publication · 27493204 (PubMed) · PMC5034041 (PubMed Central)
  4. Video-EEG results and clinical characteristics in patients with psychogenic nonepileptic spells: The effect of a coexistent epilepsy. Chen-Block S, Abou-Khalil BW, Arain A, Haas KF, Lagrange AH, Gallagher MJ, Azar NJ, Singh P, Sonmezturk HH (2016) Epilepsy Behav : 62-5
    › Primary publication · 27450307 (PubMed)
  5. Generalized onset seizures with focal evolution (GOFE) - A unique seizure type in the setting of generalized epilepsy. Linane A, Lagrange AH, Fu C, Abou-Khalil B (2016) Epilepsy Behav : 20-9
    › Primary publication · 26619379 (PubMed)
  6. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences. Grier MD, Carson RP, Lagrange AH (2015) Behav Brain Res : 260-267
    › Primary publication · 26028516 (PubMed) · PMC4496262 (PubMed Central)
  7. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells. Grier MD, Carson RP, Lagrange AH (2015) PLoS One 10(4): e0124649
    › Primary publication · 25894543 (PubMed) · PMC4403805 (PubMed Central)
  8. Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experience. Ladner TR, Morgan CD, Pomerantz DJ, Kennedy VE, Azar N, Haas K, Lagrange A, Gallagher M, Singh P, Abou-Khalil BW, Arain AM (2015) Epilepsia 56(5): e63-7
    › Primary publication · 25809720 (PubMed)
  9. Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits. Lo WY, Lagrange AH, Hernandez CC, Gurba KN, Macdonald RL (2014) Neurochem Res 39(6): 1088-103
    › Primary publication · 24213971 (PubMed) · PMC4018433 (PubMed Central)
  10. Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S (2013) J Neurol Sci 331(1-2): 67-71
    › Primary publication · 23759502 (PubMed)
  11. Suppression of thalamocortical oscillations following traumatic brain injury in rats. Kao C, Forbes JA, Jermakowicz WJ, Sun DA, Davis B, Zhu J, Lagrange AH, Konrad PE (2012) J Neurosurg 117(2): 316-23
    › Primary publication · 22631688 (PubMed)
  12. Differentiating parasomnias from nocturnal seizures. Boursoulian LJ, Schenck CH, Mahowald MW, Lagrange AH (2012) J Clin Sleep Med 8(1): 108-12
    › Primary publication · 22334817 (PubMed) · PMC3266329 (PubMed Central)
  13. Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating. Lo WY, Lagrange AH, Hernandez CC, Harrison R, Dell A, Haslam SM, Sheehan JH, Macdonald RL (2010) J Biol Chem 285(41): 31348-61
    › Primary publication · 20639197 (PubMed) · PMC2951209 (PubMed Central)
  14. Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit--possible relationship to AED tolerance. Azar NJ, Lagrange AH, Wang L, Song Y, Abou-Khalil BW (2010) Epilepsia 51(5): 811-7
    › Primary publication · 20067500 (PubMed)
  15. Feeling out the elephant in the room: why do temporal lobe seizures cause unconsciousness? Lagrange AH (2009) Epilepsy Curr 9(3): 84-7
    › Primary publication · 19471618 (PubMed) · PMC2685887 (PubMed Central)
  16. Benzodiazepine modulation of GABA(A) receptor opening frequency depends on activation context: a patch clamp and simulation study. Bianchi MT, Botzolakis EJ, Lagrange AH, Macdonald RL (2009) Epilepsy Res 85(2-3): 212-20
    › Primary publication · 19447010 (PubMed) · PMC2834588 (PubMed Central)
  17. Transitional sharp waves at ictal onset--a neocortical ictal pattern. Azar NJ, Lagrange AH, Abou-Khalil BW (2009) Clin Neurophysiol 120(4): 665-72
    › Primary publication · 19264545 (PubMed)
  18. Generalized-onset seizures with secondary focal evolution. Williamson R, Hanif S, Mathews GC, Lagrange AH, Abou-Khalil B (2009) Epilepsia 50(7): 1827-32
    › Primary publication · 19260942 (PubMed)
  19. Folic acid supplementation for women with epilepsy who might become pregnant. Lagrange AH (2009) Nat Clin Pract Neurol 5(1): 16-7
    › Primary publication · 19129787 (PubMed)
  20. Achieving synaptically relevant pulses of neurotransmitter using PDMS microfluidics. Botzolakis EJ, Maheshwari A, Feng HJ, Lagrange AH, Shaver JH, Kassebaum NJ, Venkataraman R, Baudenbacher F, Macdonald RL (2009) J Neurosci Methods 177(2): 294-302
    › Primary publication · 19013195 (PubMed) · PMC3786708 (PubMed Central)
  21. Developmental modulation of GABA(A) receptor function by RNA editing. Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB (2008) J Neurosci 28(24): 6196-201
    › Primary publication · 18550761 (PubMed) · PMC2746000 (PubMed Central)
  22. Valproate enhances neuropeptide y expression: modulating the modulators. Lagrange AH (2007) Epilepsy Curr 7(4): 107-9
    › Primary publication · 17694170 (PubMed) · PMC1941915 (PubMed Central)
  23. Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet. Harper E, Moses H, Lagrange A (2007) Neurology 68(7): 533-4
    › Primary publication · 17296923 (PubMed)
  24. Rhythmic ictal nonclonic hand (RINCH) motions: a distinct contralateral sign in temporal lobe epilepsy. Lee GR, Arain A, Lim N, Lagrange A, Singh P, Abou-Khalil B (2006) Epilepsia 47(12): 2189-92
    › Primary publication · 17201723 (PubMed)
  25. Enhanced macroscopic desensitization shapes the response of alpha4 subtype-containing GABAA receptors to synaptic and extrasynaptic GABA. Lagrange AH, Botzolakis EJ, Macdonald RL (2007) J Physiol 578(Pt 3): 655-76
    › Primary publication · 17124266 (PubMed) · PMC2151343 (PubMed Central)
  26. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Ma S, Blair MA, Abou-Khalil B, Lagrange AH, Gurnett CA, Hedera P (2006) Epilepsy Res 71(2-3): 129-34
    › Primary publication · 16839746 (PubMed)
  27. Genetic variants in absence epilepsy: a contextual consideration of calcium current kinetics. Lagrange A (2006) Epilepsy Curr 6(3): 99-101
    › Primary publication · 16761074 (PubMed) · PMC1464161 (PubMed Central)
  28. Dancing the delta shuffle: neurosteroids regulate GABAA receptor expression. Lagrange A (2006) Epilepsy Curr 6(1): 14-7
    › Primary publication · 16477317 (PubMed) · PMC1363372 (PubMed Central)
  29. Retigabine: bending potassium channels to our will. Lagrange A (2005) Epilepsy Curr 5(5): 166-8
    › Primary publication · 16175213 (PubMed) · PMC1201633 (PubMed Central)
  30. GABA receptors gone bad: the wrong place at the wrong time. Lagrange A (2005) Epilepsy Curr 5(3): 91-4
    › Primary publication · 16145612 (PubMed) · PMC1198625 (PubMed Central)
  31. Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult. Lagrange AH, Blaivas M, Gomez-Hassan D, Malow BA (2003) Epilepsy Behav 4(6): 788-92
    › Primary publication · 14698722 (PubMed)
  32. Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis. Kelly MJ, Rønnekleiv OK, Ibrahim N, Lagrange AH, Wagner EJ (2002) Steroids 67(6): 447-56
    › Primary publication · 11960620 (PubMed)
  33. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Kelly MJ, Lagrange AH, Wagner EJ, Rønnekleiv OK (1999) Steroids 64(1-2): 64-75
    › Primary publication · 10323674 (PubMed)
  34. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Lagrange AH, Ronnekleiv OK, Kelly MJ (1997) Mol Pharmacol 51(4): 605-12
    › Primary publication · 9106625 (PubMed)
  35. Tolerance to mu-opioid receptor agonists but not cross-tolerance to gamma-aminobutyric acid(B) receptor agonists in arcuate A12 dopamine neurons with chronic morphine treatment. Wagner EJ, Zhang G, Lagrange AH, Rønnekleiv OK, Kelly MJ (1997) J Pharmacol Exp Ther 280(2): 1057-64
    › Primary publication · 9023324 (PubMed)
  36. Estrogen rapidly attenuates a GABAB response in hypothalamic neurons. Lagrange AH, Wagner EJ, Rønnekleiv OK, Kelly MJ (1996) Neuroendocrinology 64(2): 114-23
    › Primary publication · 8857605 (PubMed)
  37. Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine. Zhang G, Lagrange AH, Rønnekleiv OK, Kelly MJ (1996) J Pharmacol Exp Ther 277(1): 551-8
    › Primary publication · 8613967 (PubMed)
  38. The potency of mu-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17 beta-estradiol. Lagrange AH, Ronnekleiv OK, Kelly MJ (1994) J Neurosci 14(10): 6196-204
    › Primary publication · 7931572 (PubMed) · PMC6576966 (PubMed Central)
  39. Estradiol-17 beta and mu-opioid peptides rapidly hyperpolarize GnRH neurons: a cellular mechanism of negative feedback? Lagrange AH, Rønnekleiv OK, Kelly MJ (1995) Endocrinology 136(5): 2341-4
    › Primary publication · 7720682 (PubMed)

Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    465 21st ave S
    Vanderbilt University
    6144 Medical Research Building #3
    Nashville, TN 37240-7915
    6153225979 (p)
    6153225517 (f)

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Age of Onset Alleles Astrocytes Azathioprine Brain Injuries Cell Line Cerebral Cortex Electrodes Evoked Potentials GABA-B Receptor Agonists GABA Antagonists Immunohistochemistry Magnetic Resonance Imaging Neuroglia Orexins Ovariectomy Phenotype Polysaccharides Protein Subunits Psychophysiologic Disorders Receptors, Estrogen Risk Factors RNA Editing Seizures Sensitivity and Specificity Severity of Illness Index Thalamus Treatment Outcome Triazines White Matter